Lori Mercurio

Lori Mercurio currently serves as Vice President of Strategy and Strategic Initiatives for the Pharma Services Group at Thermo Fisher Scientific since March 2021. With extensive expertise in business development and strategic initiatives, Lori Mercurio has held key leadership roles at Mallinckrodt Pharmaceuticals since 2013, driving growth in immunology and critical care through strategic partnerships, optimizing portfolios, and enhancing stakeholder value. Notable achievements include identifying $350 million in revenue from investment opportunities and leading transformative programs and operational carve-outs. Lori Mercurio's professional background also includes significant roles in quality management and project leadership at Covidien, KV Pharmaceutical, and Sanofi, complemented by an Executive MBA from Washington University in St. Louis and advanced degrees in Biology and Quality Management.